Cargando…

Stealth Liposomal Chemotherapeutic Agent for Triple Negative Breast Cancer with Improved Pharmacokinetics

Triple-negative breast cancer is one of the most lethal cancers. Chemotherapeutics for targeting CDK4 and CDK6 like Palbociclib (PAB) in triple-negative breast cancer was widely explored. However, poor bioavailability and severe side effects profile limiting its clinical usage in the field of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kommineni, Nagavendra, Paul, David, Saka, Raju, Khan, Wahid, Nanjappan, Satheeshkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428924/ https://www.ncbi.nlm.nih.gov/pubmed/36051857 http://dx.doi.org/10.7150/ntno.76370

Ejemplares similares

Liposomal Formulations in Clinical Use: An Updated Review
por: Bulbake, Upendra, et al.
Publicado: (2017)

Anabolic Peptide-Enriched Stealth Nanoliposomes for Effective Anti-Osteoporotic Therapy
por: Salave, Sagar, et al.
Publicado: (2022)

Flurbiprofen-Loaded Stealth Liposomes: Studies on the Development, Characterization, Pharmacokinetics, and Biodistribution
por: Begum, MY, et al.
Publicado: (2012)

Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine
por: Chen, Jun, et al.
Publicado: (2012)

Surface Engineering of Liposomes for Stealth Behavior
por: Nag, Okhil K., et al.
Publicado: (2013)

Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects
por: Kommineni, Nagavendra, et al.
Publicado: (2019)

A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer
por: Deng, Jiaojiao, et al.
Publicado: (2021)

Stealth Liposomes (PEGylated) Containing an Anticancer Drug Camptothecin: In Vitro Characterization and In Vivo Pharmacokinetic and Tissue Distribution Study
por: Sivadasan, Durgaramani, et al.
Publicado: (2022)

Versatility of Liposomes for Antisense Oligonucleotide Delivery: A Special Focus on Various Therapeutic Areas
por: Gupta, Raghav, et al.
Publicado: (2023)

Comparison of Conventional Chemotherapy, Stealth Liposomes and Temperature-Sensitive Liposomes in a Mathematical Model
por: Gasselhuber, Astrid, et al.
Publicado: (2012)

Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation
por: Begum, M. Yasmin, et al.
Publicado: (2022)

Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer
por: Khan, David R, et al.
Publicado: (2015)

Correlation between radioactivity and chemotherapeutics of the (111)In-VNB-liposome in pharmacokinetics and biodistribution in rats
por: Lee, Wen-Chuan, et al.
Publicado: (2012)

Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies
por: Nageeb El-Helaly, Sara, et al.
Publicado: (2017)

Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer
por: Si, Yingnan, et al.
Publicado: (2021)

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
por: Immordino, Maria Laura, et al.
Publicado: (2006)

Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer
por: Merino, Vanessa F., et al.
Publicado: (2018)

Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment
por: Winter, Marie, et al.
Publicado: (2021)

Evaluation of a natural compound extracted from Dolichandrone atrovirens as a novel antioxidant agent using Caenorhabditis elegans
por: Yellurkar, Manoj Limbraj, et al.
Publicado: (2021)

Engineering Remotely Triggered Liposomes to Target Triple Negative Breast Cancer
por: Sneider, Alexandra, et al.
Publicado: (2017)

Intracellular persister: A stealth agent recalcitrant to antibiotics
por: Personnic, Nicolas, et al.
Publicado: (2023)

In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer
por: Frik, Malgorzata, et al.
Publicado: (2014)

High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours
por: Koukourakis, M I, et al.
Publicado: (2000)

Targeting doxorubicin encapsulated in stealth liposomes to solid tumors by non thermal diode laser
por: Ghannam, Magdy M., et al.
Publicado: (2016)

Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties In Vivo
por: Giulimondi, Francesca, et al.
Publicado: (2022)

Inclusion Complex between Local Anesthetic/2-hydroxypropyl-β-cyclodextrin in Stealth Liposome
por: Souza, Gredson Keiff, et al.
Publicado: (2022)

Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives
por: Butreddy, Arun, et al.
Publicado: (2021)

A Comprehensive Review of mRNA Vaccines
por: Gote, Vrinda, et al.
Publicado: (2023)

Stealth Liposomes Encapsulating a Potent ACAT1/SOAT1 Inhibitor F12511: Pharmacokinetic, Biodistribution, and Toxicity Studies in Wild-Type Mice and Efficacy Studies in Triple Transgenic Alzheimer’s Disease Mice
por: De La Torre, Adrianna L., et al.
Publicado: (2023)

The Stealth Virus
por: Tang, Julian W.
Publicado: (2013)

FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis
por: Yang, Hua, et al.
Publicado: (2020)

Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
por: Guo, Peng, et al.
Publicado: (2019)

(99m)Tc-labelled Stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours
por: Laverman, P, et al.
Publicado: (2002)

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.
por: Goren, D., et al.
Publicado: (1996)

Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system
por: Aoyama, Katsuyuki, et al.
Publicado: (2017)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
por: Hill, Claudia, et al.
Publicado: (2021)

Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis
por: Shen, Li-wen, et al.
Publicado: (2021)

Indocyanine Green-Parthenolide Thermosensitive Liposome Combination Treatment for Triple-Negative Breast Cancer
por: Jin, Xin, et al.
Publicado: (2020)

ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
por: Guo, Peng, et al.
Publicado: (2016)

Reply: (99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx®) in glioblastomas and metastatic brain tumours
por: Koukourakis, M I
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_govjlufjssffndcp7dn0471uim